When combined with anti-PD1 therapy, the HPAEs nanovector demonstrated significant potential in remodeling the TME, promoting infiltration of dendritic cells and cytotoxic CD8+ T cells into the tumor, thereby inhibiting metastasis in E0771 tumor-bearing mice [258]. The gene discussed is CD8A; the disease is neoplasm.